Back to the Arizona Wildcats Newsfeed

Questions remain about Allonzo Trier's NBA stock and PED use

TUCSON – Among the many questions still remaining about Allonzo Trier is whether his PED-related suspension will affect his NBA stock.

Trier wasn’t a surefire NBA first-round pick last spring when he opted to return as a sophomore, and he’s now sitting at No. 57 in Draft Express’ latest mock 2017 draft. That isn’t upward momentum.

What if Trier was the Wildcats’ leading scorer? Half of a 1-2 punch with projected lottery pick Lauri Markkanen? What if Trier hit a game-winner to beat Butler at the buzzer, and the Wildcats were now 17-1 and ranked in the Top 5?